LLY

1,121.73

-0.42%↓

JNJ

234.77

-0.59%↓

ABBV

221.66

+0.03%↑

UNH

408.3

-1.05%↓

MRK

115.04

-0.36%↓

LLY

1,121.73

-0.42%↓

JNJ

234.77

-0.59%↓

ABBV

221.66

+0.03%↑

UNH

408.3

-1.05%↓

MRK

115.04

-0.36%↓

LLY

1,121.73

-0.42%↓

JNJ

234.77

-0.59%↓

ABBV

221.66

+0.03%↑

UNH

408.3

-1.05%↓

MRK

115.04

-0.36%↓

LLY

1,121.73

-0.42%↓

JNJ

234.77

-0.59%↓

ABBV

221.66

+0.03%↑

UNH

408.3

-1.05%↓

MRK

115.04

-0.36%↓

LLY

1,121.73

-0.42%↓

JNJ

234.77

-0.59%↓

ABBV

221.66

+0.03%↑

UNH

408.3

-1.05%↓

MRK

115.04

-0.36%↓

Insulet Corp

Отворен

СекторЗдравеопазване

147.13 -0.35

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

146.07

Максимум

149.3

Ключови измерители

By Trading Economics

Приходи

-11M

91M

Продажби

-22M

762M

P/E

Средно за сектора

35.482

49.052

EPS

1.3

Марж на печалбата

11.96

Служители

5,400

EBITDA

-23M

154M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+53.21% upside

Дивиденти

By Acuity

Следващи печалби

6.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.4B

10B

Предишно отваряне

147.48

Предишно затваряне

147.13

Настроения в новините

By Acuity

68%

32%

306 / 342 Класиране в Healthcare

Insulet Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Относно Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat